Found: 3
Select item for more details and to access through your institution.
PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 11, p. 6037, doi. 10.3390/ijms23116037
- By:
- Publication type:
- Article
Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in Glioblastoma.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 20, p. 2498, doi. 10.3390/cells12202498
- By:
- Publication type:
- Article
The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine
- Published in:
- FEBS Letters, 2005, v. 579, n. 27, p. 6128, doi. 10.1016/j.febslet.2005.09.084
- By:
- Publication type:
- Article